Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/01/22
End: 11/28/24
Due: 11/28/25
Phase: N/A
Priority: Normal
Start: 05/23/23
End: 02/26/25
Due: 02/26/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of ATH434 in Participants with Multiple System Atrophy | NCT05109091 | Alterity Therapeutics | user2@example.com | None | 2022-07-01 | 2024-11-28 | 2025-11-28 | - | - | 2025-07-14 |
| A Biomarker Study of ATH434 in Participants With MSA | NCT05864365 | Alterity Therapeutics | user2@example.com | None | 2023-05-23 | 2025-02-26 | 2026-02-26 | - | - | 2025-07-14 |